SNBIF
Price:
$3.85
Market Cap:
$40.29B
SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, spinal cord injury, Parkinson's disease, Alzheimer's disease, and others; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis. The company was founded in 2001 and is headquartered in Tokyo, Japan.[Read more]
Industry
Biotechnology
IPO Date
2015-10-12
Stock Exchange
PNK
Ticker
SNBIF
According to SanBio Company Limited’s latest financial reports and current stock price. The company's current PE Ratio is -18.33. This represents a change of -62.52% compared to the average of -48.90 of the last 4 quarters.
The mean historical PE Ratio of SanBio Company Limited over the last ten years is -36.94. The current -18.33 PE Ratio has changed 4.86% with respect to the historical average. Over the past ten years (40 quarters), SNBIF's PE Ratio was at its highest in in the October 2022 quarter at 52.46. The PE Ratio was at its lowest in in the October 2023 quarter at -102.58.
Average
-36.94
Median
-27.69
Minimum
-171.85
Maximum
22.54
Discovering the peaks and valleys of SanBio Company Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 236.35%
Maximum Annual PE Ratio = 22.54
Minimum Annual Increase = -277.51%
Minimum Annual PE Ratio = -171.85
Year | PE Ratio | Change |
---|---|---|
2024 | -14.51 | 94.74% |
2023 | -7.45 | -37.81% |
2022 | -11.98 | -50.05% |
2021 | -23.99 | -39.45% |
2020 | -39.62 | -76.94% |
2019 | -171.85 | 236.35% |
2018 | -51.09 | 62.74% |
2017 | -31.40 | -21.54% |
2016 | -40.02 | -277.51% |
2015 | 22.54 | -140.07% |
The current PE Ratio of SanBio Company Limited (SNBIF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-11.32
5-year avg
-19.51
10-year avg
-36.94
SanBio Company Limited’s PE Ratio is less than Alector, Inc. (-3.17), greater than Legend Biotech Corporation (-27.94), less than Ascendis Pharma A/S (-13.53), less than Cytokinetics, Incorporated (-10.31), greater than Edgewise Therapeutics, Inc. (-27.83),
Company | PE Ratio | Market cap |
---|---|---|
-3.17 | $512.88M | |
-27.94 | $7.99B | |
-13.53 | $7.21B | |
-10.31 | $6.06B | |
-27.83 | $3.23B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SanBio Company Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like SanBio Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is SanBio Company Limited's PE Ratio?
How is the PE Ratio calculated for SanBio Company Limited (SNBIF)?
What is the highest PE Ratio for SanBio Company Limited (SNBIF)?
What is the 3-year average PE Ratio for SanBio Company Limited (SNBIF)?
What is the 5-year average PE Ratio for SanBio Company Limited (SNBIF)?
How does the current PE Ratio for SanBio Company Limited (SNBIF) compare to its historical average?